The semaglutide plateau troubleshooting guide covers common reasons for stalling, and CagriSema represents a pharmacological solution to that plateau by engaging an entirely new receptor system
Lifespan data Published rodent longevity studies from Khavinson's group report epitalon extending median and maximum lifespan by 1224%, alongside reduced tumor incidence rates
Researchers have studied BPC-157 for its potential effects on: Tissue repair Tendon healing Muscle recovery Joint health Inflammation Gastrointestinal health Because of these potential benefits, BPC-157 has become popular among athletes, active adults, and individuals looking for additional recovery support
A typical therapeutic dose for humans ranges from 0.25 to 2 mL per injection
British Journal of Dermatology
Gouverneur M, Spaan JA, Pannekoek H, Fontijn RD, Vink H